R&D Systems Recombinant Human EPCR Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9557ER050
DescriptionThe Recombinant Human EPCR is derived from NS0. The Recombinant Human EPCR has been validated for the following applications: Bioactivity.
|>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|Mouse myeloma cell line, NS0-derived Ser18-Ser210, with a C-terminal 10-His tag|
|<0.10EU per 1μg of the protein by the LAL method.|
|Lyophilized from a 0.2μm filtered solution in PBS.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|APC receptor, CCCA, CCD41, CCD41centrosome-associated protein, CD201, CD201 antigen, centrocyclin, Endothelial cell protein C receptor, endothelial protein C receptor, EPCRMGC23024, PROCR, protein C receptor, endothelial|
|Reconstitute at 500μg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok